| Literature DB >> 18823570 |
Bor-Sen Chen1, Shih-Kuang Yang, Chung-Yu Lan, Yung-Jen Chuang.
Abstract
BACKGROUND: Inflammation is a hallmark of many human diseases. Elucidating the mechanisms underlying systemic inflammation has long been an important topic in basic and clinical research. When primary pathogenetic events remains unclear due to its immense complexity, construction and analysis of the gene regulatory network of inflammation at times becomes the best way to understand the detrimental effects of disease. However, it is difficult to recognize and evaluate relevant biological processes from the huge quantities of experimental data. It is hence appealing to find an algorithm which can generate a gene regulatory network of systemic inflammation from high-throughput genomic studies of human diseases. Such network will be essential for us to extract valuable information from the complex and chaotic network under diseased conditions.Entities:
Year: 2008 PMID: 18823570 PMCID: PMC2567339 DOI: 10.1186/1755-8794-1-46
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Figure 1The flow chart for constructing the gene regulatory network of inflammation. The left-hand-side path selects target genes and their potential regulatory genes, and the right-hand-side path generates a threshold of Cross correlation between each target gene and its upstream regulator to select possible regulatory genes from the left-hand-side path to construct a rough gene regulatory network of inflammatory response. Then the rough gene regulatory network is pruned by dynamic model and parsimonious Akaike Information Criterion to achieve a refined gene regulatory network of inflammation.
Total 49 genes selected from published literatures
| ATP-binding cassette, sub-family F (GCN20), member 1 | interleukin 22 | ||
| Adenosine A2a receptor | interleukin 6 | ||
| Adenosine A3 receptor | interleukin 8 | ||
| Arachidonate 5-lipoxygenase | Interleukin-1 receptor-associated kinase 1 | ||
| Alpha-1-microglobulin/bikunin precursor | integrin, beta 2 | ||
| Annexin A1 | kininogen | ||
| Acyloxyacyl hydrolase (neutrophil) | mitogen-activated protein kinase 10 | ||
| B-cell linker | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 | ||
| Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | ||
| Chemokine (C-C motif) receptor 7 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | ||
| CCAAT/enhancer binding protein (C/EBP), delta | Nuclear factor related to kappa B binding protein | ||
| Chemokine (C-X-C motif) ligand 14 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | ||
| chemokine (C-X-C motif) ligand 2 | Phospholipase A2, group IVB (cytosolic) | ||
| Cytochrome b-245, beta polypeptide (chronic granulomatous disease) | phospholipase A2-activating protein | ||
| V-fos FBJ murine osteosarcoma viral oncogene homolog | pancreatitis-associated protein | ||
| G protein-coupled receptor 132 | kallikrein 7 (chymotryptic, stratum corneum) | ||
| Histone deacetylase 4 | Small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) | ||
| Histone deacetylase 5 | Tachykinin receptor 1 | ||
| Histone deacetylase 7A | Toll-like receptor adaptor molecule 2 | ||
| Histone deacetylase 9 | toll-like receptor 4 | ||
| heparanase | toll-like receptor 7 | ||
| interleukin 17C | tumor necrosis factor | ||
| interleukin 1a | Tumor necrosis factor receptor superfamily member 1A precursor | ||
| interleukin 1b | Toll interacting protein | ||
| Interleukin-1 receptor type I precursor |
Figure 2Distribution of a threshold for selecting candidate regulators by Cross correlation method. 2000 genes are randomly chosen from 22577 genes to compute their correlation and then these correlations are ranked. A threshold 0.3 is specified to select possible candidate regulators from those based on DNA sequence similarity in JASPAR database.
Figure 3The inflammatory transcriptional gene network in immune system with LPS. The inflammatory gene network with LPS containing.
Figure 4The inflammatory transcriptional gene network in immune system without LPS. The inflammatory gene network in normal condition.
Figure 5The perturbed transcriptional gene network. Gene network only in normal condition but not inflammatory condition.
Figure 6The perturbed transcriptional gene network. Gene network only in inflammatory condition but not in normal condition.
Gene Connectivity only in inflammatory condition but not in normal condition
| Regulator | Connectivity | Reference |
| FOXL1 | 23 | [ |
| TFAP2A | 19 | [ |
| SOX9 | 16 | [ |
| GATA2 | 12 | [ |
| AML1 | 11 | [ |
| NR3C1 | 8 | [ |
Figure 7The important proinflammatory gene network induced or activated by NF-. The important proinflammatory gene network in inflammatory condition.
Figure 8The important proinflammatory gene network induced or activated by NF-. The important proinflammatory gene network in normal condition.
Figure 9The important proinflammatory perturbed NF-. Gene network only in normal condition but not inflammatory condition.
Figure 10The important proinflammatory perturbed NF-. Gene network only in inflammatory condition but not in normal condition.
Figure 11The curve fittings of dynamic regulatory model of proinflammatory gene and its regulators. The 'o' is the data from microarray in 24 hours and the solid line is the curve fitting by the proposed dynamic model in equation (1). The error bars for standard deviations have been marked. We denoted the curve fittings of 9 target genes and their upstream regulators respectively, and the regulatory parameters for each dynamic model are presented [see Additional file 5 and 6]